UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Azerbaijan Premier League round 12 concludes today

Aoun warns Iran against interfering in Lebanon

Azerbaijan congratulates Lebanon on National Day

Slovakia refuses to join new EU loan for Ukraine

Fenerbahce held to 2-2 draw by Kocaelispor

US realises it cannot win trade or hot war with China

Mexico arrests FBI's most-wanted drug lord

France sees lower protest turnout, 144 detained

Fidan: Turkiye's policy focuses on Saudi Arabia's defence

Aliyev releases video summarizing Vietnam visit - Video

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla